Solid Biosciences Inc. (SLDB) insider trading

By person

12 insiders · 29 transactions

2.0×

Alexander Cumbo holds only 2.0 times base salary in stock. $1.32M of shares against $650.99K in salary for 2025.

Salary from the company's own proxy. The shares are what Alexander Cumbo last reported holding, valued at $5.62, the price Common Stock was last bought or sold at on the open market here, on 19 Oct 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Alexander Cumbo

President and CEO

—

$983.86K (4) scheduled

−$983.86K

235,405

0.2195%

$1.32M

+758.5%

David T Howton

Chief Operating Officer

—

$433.54K (4) scheduled

−$433.54K

105,077

0.0980%

$590.53K

+1,267%

Kevin Tan

CFO & Treasurer

—

$329.51K (4) scheduled

−$329.51K

99,422

0.0927%

$558.75K

+283.6%

Jessie Hanrahan

Chief Regulatory Officer

—

$297.33K (4) scheduled

−$297.33K

74,318

0.0693%

$417.67K

+964.3%

Gabriel Brooks

Chief Medical Officer

—

$288.24K (4) scheduled

−$288.24K

97,241

0.0907%

$546.49K

+379.7%

Paul Herzich

Chief Technology Officer

—

$274.08K (4) scheduled

−$274.08K

72,638

0.0677%

$408.23K

+453.5%

Ilan Ganot

Director

—

$82.37K (5) scheduled

−$82.37K

126,771

0.1182%

$712.45K

+20.9%

Perceptive Advisors LLC entity

Director

—

11,833,539

11.04%

$66.50M

+73.2%

Bain Capital Life Sciences Investors, LLC entity

10% owner

—

5,034,582

4.70%

$28.29M

+24.8%

Adage Capital Management, L.P. entity

10% owner

—

4,248,084

3.96%

$23.87M

+6.3%

Ian F Smith

Director

—

141,585

0.1320%

$795.71K

+29.0%

Clare Kahn

Director

—

2,960

0.0028%

$16.64K

+169.1%

Solid Biosciences Inc.

What the insiders did Mostly scheduled

By person